What is Discuva?
Discuva Limited, established in 2011 in Cambridge, UK, is a privately held biotechnology company revolutionizing the speed and methodology of new antibiotic discovery. The company's core focus is on the identification, development, and commercialization of novel antibiotics designed to combat multi-drug resistant bacterial pathogens. Their innovative platform represents a paradigm shift in addressing the growing global threat of antimicrobial resistance.
How much funding has Discuva raised?
Discuva has raised a total of $1.9M across 1 funding round:
Grant
$1.9M
Grant (2017): $1.9M, investors not publicly disclosed
What's next for Discuva?
With this substantial backing, Discuva is poised to accelerate its research and development initiatives, further refining its platform and advancing its pipeline of novel antibiotics. The strategic investment signals confidence in Discuva's approach to tackling critical unmet needs in infectious disease treatment, positioning the company for significant growth and impact in the global fight against antibiotic-resistant bacteria.
See full Discuva company page
